Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

17.880
+1.5809.69%
Volume:24.80M
Turnover:439.42M
Market Cap:39.14B
PE:-9.28
High:18.300
Open:16.730
Low:16.480
Close:16.300
52wk High:19.400
52wk Low:10.360
Shares:2.19B
HK Float Shares:2.19B
Volume Ratio:1.86
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.928
ROE:-12.85%
ROA:3.15%
PB:1.26
PE(LYR):-9.28
PS:5.20

Loading ...

CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance

Stock News
·
27 mins ago

Movement Alert|GENSCRIPT BIO Rises 5.15% in Regular Trading, CARVYKTI Q2 Sales Surge Nearly 50% YoY Combined with Pipeline Progress

Market Focus
·
1 hour ago

Movement Alert|GENSCRIPT BIO Rises 6.04% in Regular Trading, CARVYKTI Q2 Sales Surge Nearly 50% YoY Continues to Boost Sentiment

Market Focus
·
Yesterday

Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%

Stock News
·
Jul 31

Movement Alert|GENSCRIPT BIO Rises 5.47% in Regular Trading, CARVYKTI Q2 Sales Surge Nearly 50% Year-over-Year Boosting Sentiment

Market Focus
·
Jul 31

Selling US$5.8m Of Stock Was Lucrative Decision For Genscript Biotech Insiders

Simply Wall St.
·
Jul 28

Movement Alert|GENSCRIPT BIO Intraday Rise 5.38%, CARVYKTI Q2 Sales Up Nearly 50% YoY Fueling Continued Technical Recovery

Market Focus
·
Jul 23

Market Analysis: Tech Stocks Retreat on Capex Worries, Gold Gains on Safe-Haven Logic

Stock News
·
Jul 22

Movement Alert|Genscript Biotech Rises 5.12% in Regular Trading, WAIC AI Bio-Manufacturing Platform Showcase Extends Technical Rebound

Market Focus
·
Jul 22

Movement Alert|Genscript Biotech Rises 5.6% in Regular Trading, WAIC AI Biomanufacturing Platform Showcase and Sector Rebound Boost Sentiment

Market Focus
·
Jul 20

Movement Alert|Genscript Biotech Falls 5.18% in Regular Trading, CARVYKTI Q2 Sales Growth Deceleration Extends Profit-Taking Pressure

Market Focus
·
Jul 17

Genscript Associate Reports $657 Million in Carvykti Sales Under License Agreement

MT Newswires Live
·
Jul 16

Movement Alert|GenScript Biotech Falls 6.34% in Regular Trading, CARVYKTI Q2 Sales Growth Deceleration Triggers Profit-Taking

Market Focus
·
Jul 16

Genscript Biotech: Associate Legend Biotech Posts US$657.00 Million Q2 Sales for CARVYKTI®

Bulletin Express
·
Jul 15

GENSCRIPT BIO Reports Q2 Net Trade Sales of CARVYKTI® at Approximately $657 Million

Stock News
·
Jul 15

Movement Alert|Genscript Biotech Rises 5.04% in Regular Trading, CXO Sector Interim Results Beat Expectations Driving Sector Momentum

Market Focus
·
Jul 15

Movement Alert|Genscript Biotech Rises 5.27% in Regular Trading, CXO Sector Mid-Year Earnings Window Continues to Catalyze

Market Focus
·
Jul 13

Movement Alert|Genscript Biotech Rises 5.38% in Regular Trading, CXO Sector Rallies as Mid-Year Earnings Window Opens with Policy Tailwinds

Market Focus
·
Jul 10

Movement Alert|GenScript Biotech Rises 5.07% in Regular Trading, AI Drug Discovery Theme Drives Sector-Wide Rally

Market Focus
·
Jul 06

Movement Alert|Genscript Biotech Rises 6.46% in Regular Trading, Trading at HK$13.14

Market Focus
·
Jul 02